A third type of lymphocyte, known as a natural killer or NK cell, comes from the same place as B and T cells. NK cells respond quickly to several foreign substances and are specialized in killing ...
A novel cell therapy approach using cord blood-derived natural killer (NK) cells pre-complexed with AFM13, or acimtamig, a CD30/CD16A bispecific antibody, was safe and generated strong response rates ...
NK cells have innate advantages over T cells that translate into superior ... cell therapy platform and complementary bispecific NK cell engagers. NK cells readily penetrate tumors, are free ...
Inga Rødahl from the Center for Infectious Medicine (CIM) at the Department of Medicine, Huddinge (MedH) is defending her ...
Creating cancer therapies based around natural killer cells could offer similar levels of efficacy to CAR-T therapies, but at around one hundredth of the cost. Researchers at MD Anderson Cancer ...
Silencing KLF2 drove the CD8 T cells along a different path, directing them away from becoming killer cells and toward a ...
HCW Biologics Inc. (the “Company” or “HCW Biologics”) (NASDAQ: HCWB), a clinical-stage biopharmaceutical company focused on ...
Wugen, Inc. is a clinical-stage U.S. biotechnology company developing the next generation of off-the-shelf CAR-T and memory natural killer (NK) cell therapies for cancer. For more information, please ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results